Dextroamphetamine SulfateExtended-ReleaseExtended-Release (Impax Generics)
Welcome to the PulseAid listing for the Dextroamphetamine SulfateExtended-Release drug offered from Impax Generics. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Impax Generics |
| NON-PROPRIETARY NAME: | Dextroamphetamine Sulfate |
| SUBSTANCE NAME: | DEXTROAMPHETAMINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 1976-08-02 |
| END MARKETING DATE: | 0000-00-00 |
Dextroamphetamine SulfateExtended-Release Extended-Release HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dextroamphetamine SulfateExtended-Release Extended-Release from Impax Generics |
| LABELER NAME: | Impax Generics |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 1976-08-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0115-1702_6301d0f3-fb67-4a63-bf16-845c76a5b4a0 |
| PRODUCT NDC: | 0115-1702 |
| APPLICATION NUMBER: | NDA017078 |
Other DEXTROAMPHETAMINE SULFATE Pharmaceutical Manufacturers / Labelers:
| Manufacturer / Labeler | Proprietary Name |
| Actavis Pharma, Inc. | dextroamphetamine sulfate |
| Amedra Pharmaceuticals LLC | DEXEDRINE |
| American Health Packaging | Dextroamphetamine Sulfate |
| Arbor Pharmaceuticals, Inc. | Zenzedi |
| Aurolife Pharma, LLC | DEXTROAMPHETAMINE SULFATE |
| Avadel Generics, LLC | dextroamphetamine sulfate |
| Avera McKennan Hospital | DEXTROAMPHETAMINE SULFATE |
| Ethex Corporation | dextroamphetamine sulfate |
| FSC Laboratories, Inc | ProCentra |
| Impax Generics | Dextroamphetamine SulfateExtended-Release |
| Independence Pharmaceuticals, LLC | Procentra |
| KVK-Tech, Inc. | Dextroamphetamine Sulfate |
| Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC | Dextroamphetamine Sulfate |
| Lineage Therapeutics Inc | Dextroamphetamine Sulfate |
| Lupin Pharmaceuticals,Inc. | Dextroamphetamine Sulfate |
| Mallinckrodt, Inc. | DEXTROAMPHETAMINE SULFATE |
| Mayne Pharma Inc. | dextroamphetamine sulfate |
| Mikart, Inc. | dextroamphetamine sulfate |
| Mylan Pharmaceuticals Inc. | Dextroamphetamine Sulfate |
| Novel Laboratories, Inc. | Dextroamphetamine Sulfate |
| Physicians Total Care, Inc. | Dextroamphetamine Sulfate |
| Teva Pharmaceuticals USA, Inc. | Dextroamphetamine Sulfate |
| Teva Pharmaceuticals, USA, Inc. | Dextroamphetamine Sulfate |
| Tris Pharma Inc | Dextroamphetamine |
| Wilshire Pharmaceuticals, Inc. | Dextroamphetamine Sulfate |
| Zydus Pharmaceuticals (USA) Inc. | DEXTROAMPHETAMINE SULFATE |
